Lemaitre Vascular (LMAT) Cash from Restructuring (2011)

Lemaitre Vascular (LMAT) reported Cash from Restructuring of -$7000.0 for Q4 2011, down 600.0% quarter-over-quarter from -$1000.0 in Q3 2011.

Lemaitre Vascular (LMAT) Cash from Restructuring (2011) Analysis & Trends

Lemaitre Vascular (LMAT) has 1 years of Cash from Restructuring data on file, last reported at -$7000.0 in Q4 2011.

Cash from Restructuring for Q4 2011 came in at -$7000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2011 was -$732000.0 (changed N/A YoY), and the FY2011 annual result was -$732000.0, down 577.78% from the prior year.
Cash from Restructuring fell to -$7000.0 in Q4 2011 per LMAT's latest filing, from -$1000.0 in the prior quarter.
Over five years, Cash from Restructuring peaked at -$1000.0 in Q3 2011 and troughed at -$709000.0 in Q1 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Lemaitre Vascular	2.12 Bn	1.75 Bn	48.40 Mn

Download Data